Key facts
- This page summarizes David A. Ricks's Form 4 filing for ELI LILLY & Co (LLY).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 12 Aug 2025, 16:23.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $644.45 to $645.11, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Footnote F2
Includes 16 shares previously held in a family member's retirement account.
Footnote F3
On May 15, 2025, 5,340 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.
Footnote F4
The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.